Do Sleeping Pills Hurt Sleep Quality?

👋 Welcome to this edition of Sleepletter™ where we offer you easy-to-read insights from the latest research papers from the field of sleep neurobiology and clinical sleep medicine. Sign up to also receive Sleepletter by email.

🏆 Want to optimize your sleep or attend my "Ask Me Anything" session? Join us for exclusive seminars and events that unveil the science of sleep and receive personalized, actionable and science-backed recommendations how to improve sleep. Subscribe here!

🎧 NEW! Sleepletter is now on Spotify—not just an audio version of the newsletter, but a deeper, more dynamic dive into each topic, exploring the science of sleep in a way that informs and surprises.

Millions of people take something at night to “switch off.” The lights go out, the room gets quiet, and morning suggests the plan worked. But here’s the part we don’t say often enough: not all sleep is the same. Many sleep medicines nudge the brain toward unconsciousness—often trading sleep depth and timing for sedation. That distinction matters, because the way sleep is built (its stages and cycles), not just its length, drives recovery, memory, mood, immunity, and the way you feel tomorrow morning.

On a good night, the brain moves through repeating arcs: light sleep, deep slow-wave sleep, REM, then back around again. Each stage is important for certain biological functions. E.g. deep sleep is the where tissue restoration, immune tuning and memory consolidation happen. REM is when we dream and when is vital for various cognitive and emotional functions, including memory consolidation. When these stages arrive in the right proportions and at the right times, you wake feeling like yourself again. When medication rewrites that script, you can log eight hours and still open your eyes flat, foggy, or unrefreshed.

Sedative-hypnotics (e.g. lorazepam or zopiclone) are powerful tools. In acute crises—a grief-shocked week, a brutal run of jet lag, a period when anxiety won’t let the brain idle—they can be exactly the bridge someone needs. But their route into “sleep” isn’t always the route the brain would choose. Classic sedatives such as benzodiazepines (e.g. lorazepam), and their younger Z-drug cousins (e.g. zopiclone), quiet neural activity broadly and effectively. People fall asleep faster and wake less—but often at the price of thinner deep sleep, altered REM, and nights that flatten into lighter stages. Patients describe it perfectly: “I slept, but I didn’t get rest.” Regulators have also had to address next-morning impairment and rare, complex sleep behaviors with certain Z-drugs—warnings that exist precisely because sedation can outlast the night or express itself in unsafe ways.

Not all “sleep medicines” behave the same way. Low-dose antidepressants commonly used for insomnia form a mixed picture. Trazodone can lengthen total sleep and, but also suppress REM sleep. For some people, the benefit is only modest and the morning can feel cotton-wool with dry mouth or dizziness—evidence enough to use it thoughtfully rather than reflexively. Very-low-dose doxepin, which mainly taps the brain’s histamine system, is used for sleep maintenance. In trials it improved continuity with little next-day hangover at those doses and without obvious damage to sleep architecture, though sensitive users can still feel morning sedation.

Over-the-counter sedating antihistamines are the bluntest instrument. They make people drowsy, but often fragment the night into choppy pieces and bring anticholinergic effects—confusion, constipation, dry mouth—that becomes especially concerning with age; geriatric guidelines flag these agents for a reason. If you’ve ever “slept” on diphenhydramine and woken up sticky-headed, you’ve felt the difference between unconsciousness and restoration.

There’s also a newer path that takes a different philosophy. Orexin antagonists (suvorexant, lemborexant, daridorexant) don’t "club" the brain into sleep; they ease off the accelerator of wakefulness, i.e. block the action of the wake promoting neuropeptine orexin. In practice that can mean a night that feels more natural—less cognitive penalty the next day, and, in controlled trials, improvements in sleep onset and maintenance with daytime functioning benefits at higher doses of daridorexant. Importantly, emerging analyses suggest these drugs can extend sleep without distorting the proportion of non-REM and REM compared to placebo. They’re not side-effect-free, and residual sleepiness can occur.

Melatonin and ramelteon (melatonin agonist) sit in yet another bucket. They’re more about timing than force. If your body clock is misaligned—late-shift schedules, light at the wrong hours—these can help line up the timing of sleep with your internal night. Ramelteon, for example, reduced time to fall asleep in trials without meaningful damage to architecture, but it’s not a “hammer” for a racing mind.

One more nuance clinicians wrestle with: breathing at night. In people with undiagnosed obstructive sleep apnea, sedative-hypnotics can lower airway muscle tone or blunt arousal responses. The evidence is mixed and class-specific—Z-drugs may be less problematic than benzodiazepines and can even raise arousal threshold in some contexts—but the safest practice is simple: screen for sleep apnea when insomnia coexists with snoring, witnessed pauses, or non-restorative sleep, and treat the airway first. Fixing the physiology under the insomnia often changes the entire story.

Where does all this leave a person deciding what to do tonight? The most important principle isn’t purist; it’s practical. Quantity without quality isn’t victory. If a short course of medication carries you through a hard chapter, that’s a meaningful win. But if weeks turn into months and the mornings stay dull, the problem may not be the number of hours—it may be the poor sleep architecture your drug is creating. That’s the moment to revisit the plan: taper to the lowest effective dose, limit duration, consider a different class, and address the foundations that pills can’t replace. Of course, you should always consults a healthcare professional when making any treatment decisions. Cognitive Behavioral Therapy for Insomnia, however, still remains the recommended first-line treatment for chronic insomnia for precisely this reason. Light in the morning and none at night, regular sleep timing, a cooler room: none of these feel as dramatic as a pill, but they restore the very thing a healthy night depends on—timing and depth arriving when the brain expects them.

Sleeping pills can be lifesaving tools. Tools, though, shape outcomes. If we trade deep and REM sleep for quiet stillness, we get hours without renewal. And sleeping pills are not for everyone. Using them at the right time for the right person can be super beneficial—when they’re a bridge, but not a permanent home.

***

About the author

Alen Juginović is a medical doctor and postdoctoral researcher in the Department of Neurobiology at Harvard Medical School studying the effect of poor sleep quality on health. He is the author of Sleep Science Made Simple, a book that explains how sleep affects the brain and body using clear, accessible language for both professionals and the general public. He is a member of the Editorial Board of the Journal of Clinical Sleep Medicine, the official journal of the American Academy of Sleep Medicine. As a keynote speaker at conferences and teacher at Harvard College, he often discusses sleep's importance during the educational process and in media appearances. Alen is also focused on personalized sleep optimization for individuals and athletes (e.g. jet lag management), as well as being an advisor/investor/consultant for companies and individuals in the sleep field. He leads a team at Med&X Association organizing international award-winning conferences, including the Plexus Conference, which drew over 2,400 participants from 30+ countries, featuring 10 Nobel laureates and medical leaders. Med&X also collaborates with research labs and clinics from leading universities and hospitals around the world offering invaluable internships to help accelerate the development of top medical students, physicians and scientists. Feel free to contact Alen via LinkedIn for any inquiries.

Disclaimer: The content provided in this newsletter is for informational and educational purposes only. It is not intended as medical or professional advice. The reader should consult with a medical professional for medical conditions or concerns, and with a financial or legal professional regarding any other specific needs or inquiries they may have related to the material discussed.

The writer expressly disclaims responsibility, obligation, or liability for actions taken by the reader in their unique circumstances based on any guidance, suggestions or recommendations made in this newsletter related to sleep health, optimization or hygiene. This content is not a substitute for personalized medical diagnosis, treatment or care from a trained physician.

The writer has made good faith efforts to confirm that all sleep science, research or health statistics referenced from third party sources are accurately represented. However, no warranty is made as to completeness or ongoing accuracy. Readers agree any reliance on newsletter content for decision making is at their sole discretion and risk. The writer is released of liability or claims related to applied use of this general educational content on sleep physiology or best practices.